Medical Developments International Limited (ASX: MVP) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Medical Developments International Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Medical Developments International Limited (ASX: MVP)
Latest News
Technology Shares
3 hot tips from 3 top brokers for 3 under-the-radar ASX shares
Share Market News
ALL ORDINARIES finishes lower Wednesday: 8 shares you missed
Share Market News
Medical Developments Ltd International Ltd facing a world of pain in the U.S.
Share Fallers
Why these 4 ASX shares have tumbled lower today
Share Fallers
Medical Developments International Ltd (ASX:MVP) shares plunge lower on FDA news
Healthcare Shares
3 top small cap healthcare shares on my watchlist
⏸️ Investing
Insiders have been buying these ASX shares
⏸️ Investing
Great expectations of a stock can be its downfall
⏸️ Investing
ALL ORDINARIES finishes higher Monday: 8 shares you missed
⏸️ Investing
Why these 4 ASX shares have started the week in the red
⏸️ Investing
Why Medical Developments International Ltd shares have been crushed today
⏸️ Investing
3 fast-growing healthcare shares on my watchlist
Frequently Asked Questions
-
Medical Developments International has not paid a Dividend since 2019.
-
Medical Developments International Ltd listed on the ASX on 15 December 2003.
MVP ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Medical Developments International Limited
Medical Developments International Ltd (ASX: MVP) is an Australian- based pharmaceutical company. It manufactures and distributes pharmaceutical drugs covering pain management, asthma, and resuscitation, as well as medical and veterinary equipment.
The company has three business units: pharmaceuticals, medical devices, and veterinary products. The majority of its revenue comes from its pharmaceuticals segment which produces and sells the pain relief drug Penthrox within Australia, New Zealand, and the United Kingdom, as well as some sales in other countries.
